If you’ve noticed “little tiny bumps” developing on your hands or feet, there’s no reason to panic. A medical professional ...
Cautioning that this is "for general educational purposes only, not specific medical advice", he explains that if you have a ...
Pompholyx (also called dyshidrotic eczema) is a type of eczema that affects the hands or feet. It's usually a long-term condition, but treatment can help control the symptoms. The NHS suggests you ...
During the cold winter months, many people notice their skin’s condition worsens. Dry air and indoor heating can exacerbate symptoms of eczema, or atopic dermatitis. This leads to dry, cracked ...
Sanofi (EPA: SASY) has announced encouraging late-stage clinical trial results for its investigational drug amlitelimab, reinforcing its potential as a new treatment option for patients with moderate ...
The cold, dry air of winter brings challenges for those with chronic hand eczema. Chronic hand eczema (CHE), defined as hand ...
Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology, announces the planned start of a phase III study assessing the efficacy and safety of Lebrikizumab (Ebglyss ®, ...
LANSING, Mich. (WLNS) — Tens of millions of people in the U.S. suffer from eczema, a sometimes itchy and sometimes painful skin condition. Researchers overseas are using a bit of toy technology to ...
Hosted on MSN
Here for health: New buzz on eczema treatment
Trump’s pardon of convicted woman is the second time he’s erased her sentence in a criminal case 'Massive' untapped oil and gas reserves discovered beneath the Permian. What will it take to tap it?
Hosted on MSN
New device could speed up eczema treatment
Researchers are using toy-inspired technology to help relieve eczema, a painful, itchy condition affecting tens of millions in the U.S. Fundraiser for Ford worker who heckled Trump overtakes Jonathan ...
Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease mechanisms including IL-13 and therefore makes targeting IL-13 with lebrikizumab a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results